| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Selling, general & administrative | 0.2 | 0.5 | 0.8 | 1.0 | 0.5 | — | — | |
| Selling & marketing | 0.0 | 0.5 | 0.1 | 1.0 | 0.0 | — | — | |
| Operating expenses | 0.2 | 0.5 | 0.8 | 1.0 | 0.5 | 0.6 | +37.2% | |
| Operating income | (0.2) | (0.5) | (0.8) | (1.0) | (0.5) | (0.6) | −37.2% | |
| Interest expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | +6.4% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −34.6% | |
| Other income / expense | (0.2) | (0.2) | (0.2) | (0.2) | (0.2) | — | — | |
| Pre-tax income | (0.3) | (0.7) | (1.0) | (1.2) | (0.7) | 2.1 | +416.8% | |
| Income tax | (0.0) | (0.0) | (0.0) | (1.2) | 0.0 | 0.0 | — | |
| Net income | (0.3) | (0.7) | (1.0) | (1.2) | (0.7) | 2.1 | +416.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (16.30) | (29.40) | (34.50) | (29.40) | (0.01) | 0.04 | +399.3% | |
| EPS, diluted (per share) | (16.30) | (29.40) | (34.50) | (29.40) | (0.01) | 0.03 | +323.6% | |
| EBITDA | (0.2) | (0.5) | (0.8) | (1.0) | (0.5) | (0.6) | −37.2% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | — | — | |
| Weighted average shares (shares) | 20,107,400 | 23,618,500 | 27,844,100 | 41,328,200 | 47,711,000 | 49,605,469 | +4.0% | |
| Weighted average diluted shares (shares) | 20,107,400 | 23,618,500 | 27,844,100 | 41,328,200 | 47,702,900 | 66,362,965 | +39.1% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
